Siegfried Wurster
Director Técnico/Científico/I+D en Karyon-CTT Oy .
Perfil
Siegfried Wurster is Chief Scientific Officer of Karyon-CTT Oy.
Prior to joining Karyon in 2006 he was Director of Sciences at Juvantia Pharma Ltd.
Dr. Wurster holds a PhD in Chemistry from the University of Freiburg.
Cargos activos de Siegfried Wurster
| Empresas | Cargo | Inicio |
|---|---|---|
Karyon-CTT Oy
 Karyon-CTT Oy Miscellaneous Commercial ServicesCommercial Services Karyon-CTT Oy discovers and develops novel and innovative peptide-based tumor targeting systems. Its Targeting Units (TU) are intended for delivery of diagnostic imaging agents or therapeutic compounds to cancer tissue. The company was founded in 2006 and is headquartered in Helsinki, Finland. | Director Técnico/Científico/I+D | 01/01/2006 |
Antiguos cargos conocidos de Siegfried Wurster.
| Empresas | Cargo | Fin |
|---|---|---|
Juvantia Pharma Oy
 Juvantia Pharma Oy Miscellaneous Commercial ServicesCommercial Services Juvantia Pharma Oy discovers and develops pharmaceuticals and drugs. The firm develops products for the treatment of Parkinson's disease, depression and schizophrenia, vasoconstrictive disorders, fibro proliferative vasculopathies and chronic pain.The company was founded by Risto Arvo Sakari Lammintausta in 1997 and is headquartered in Turku, Finland. | Director Técnico/Científico/I+D | - |
Formación de Siegfried Wurster.
| University of Freiburg | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Juvantia Pharma Oy
Juvantia Pharma Oy Miscellaneous Commercial ServicesCommercial Services Juvantia Pharma Oy discovers and develops pharmaceuticals and drugs. The firm develops products for the treatment of Parkinson's disease, depression and schizophrenia, vasoconstrictive disorders, fibro proliferative vasculopathies and chronic pain.The company was founded by Risto Arvo Sakari Lammintausta in 1997 and is headquartered in Turku, Finland. | Commercial Services |
Karyon-CTT Oy
Karyon-CTT Oy Miscellaneous Commercial ServicesCommercial Services Karyon-CTT Oy discovers and develops novel and innovative peptide-based tumor targeting systems. Its Targeting Units (TU) are intended for delivery of diagnostic imaging agents or therapeutic compounds to cancer tissue. The company was founded in 2006 and is headquartered in Helsinki, Finland. | Commercial Services |
- Bolsa de valores
- Insiders
- Siegfried Wurster
